secwatch.observer — SEC 8-K summary
======================================

Issuer:     Encompass Health Corp (EHC)
CIK:        0000785161
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0000785161-23-000037
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Encompass Health reiterates FY2023 guidance at investor meeting on May 22
-------------------------------------------------------------------------

- Reaffirms FY2023 net operating revenue of $4,700M-$4,770M.
- Reaffirms FY2023 Adjusted EBITDA of $870M-$910M.
- Reaffirms FY2023 Adjusted EPS of $2.94-$3.23.
- CEO Mark Tarr and CFO Doug Coltharp to participate in investor meeting in Birmingham, AL on May 22, 2023.
- Guidance unchanged from April 27, 2023 earnings release and April 28, 2023 conference call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/785161/000078516123000037/0000785161-23-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/785161/000078516123000037/ehc-20230519.htm
  HTML page:      https://secwatch.observer/filing/0000785161-23-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer